GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q1 2015. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $212,000 | -1.4% | 4,867 | 0.0% | 0.06% | +5.4% |
| Q4 2021 | $215,000 | -10.0% | 4,867 | -17.0% | 0.06% | -44.0% |
| Q2 2020 | $239,000 | +7.7% | 5,867 | 0.0% | 0.10% | -8.3% |
| Q1 2020 | $222,000 | -19.6% | 5,867 | 0.0% | 0.11% | +1.9% |
| Q4 2019 | $276,000 | +10.4% | 5,867 | 0.0% | 0.11% | +1.9% |
| Q3 2019 | $250,000 | +6.4% | 5,867 | 0.0% | 0.10% | +5.0% |
| Q2 2019 | $235,000 | -4.1% | 5,867 | 0.0% | 0.10% | -6.5% |
| Q1 2019 | $245,000 | +9.4% | 5,867 | 0.0% | 0.11% | 0.0% |
| Q4 2018 | $224,000 | -15.2% | 5,867 | -10.6% | 0.11% | +2.9% |
| Q3 2018 | $264,000 | 0.0% | 6,560 | 0.0% | 0.10% | -7.1% |
| Q2 2018 | $264,000 | -46.0% | 6,560 | -50.0% | 0.11% | +7.7% |
| Q1 2018 | $489,000 | +109.9% | 13,120 | +100.0% | 0.10% | +5.1% |
| Q4 2017 | $233,000 | -12.4% | 6,560 | 0.0% | 0.10% | -16.8% |
| Q3 2017 | $266,000 | -6.0% | 6,560 | 0.0% | 0.12% | -7.8% |
| Q2 2017 | $283,000 | +2.2% | 6,560 | 0.0% | 0.13% | -5.1% |
| Q1 2017 | $277,000 | +9.5% | 6,560 | 0.0% | 0.14% | +3.0% |
| Q4 2016 | $253,000 | -54.4% | 6,560 | -48.9% | 0.13% | -14.3% |
| Q3 2016 | $555,000 | +104.0% | 12,846 | +104.4% | 0.15% | +1.3% |
| Q2 2016 | $272,000 | +28.9% | 6,286 | +21.0% | 0.15% | +27.7% |
| Q1 2016 | $211,000 | +0.5% | 5,194 | 0.0% | 0.12% | 0.0% |
| Q4 2015 | $210,000 | -2.8% | 5,194 | 0.0% | 0.12% | 0.0% |
| Q2 2015 | $216,000 | -10.0% | 5,194 | 0.0% | 0.12% | -11.2% |
| Q1 2015 | $240,000 | +8.1% | 5,194 | 0.0% | 0.13% | +10.7% |
| Q4 2014 | $222,000 | -7.1% | 5,194 | 0.0% | 0.12% | -6.9% |
| Q3 2014 | $239,000 | -14.0% | 5,194 | 0.0% | 0.13% | -13.3% |
| Q2 2014 | $278,000 | 0.0% | 5,194 | 0.0% | 0.15% | -6.2% |
| Q1 2014 | $278,000 | +0.4% | 5,194 | 0.0% | 0.16% | +1.3% |
| Q4 2013 | $277,000 | +9.9% | 5,194 | +3.6% | 0.16% | +2.6% |
| Q3 2013 | $252,000 | -25.0% | 5,015 | -25.3% | 0.15% | -26.0% |
| Q2 2013 | $336,000 | – | 6,715 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |